Chronic Allograft Nephropathy Clinical Trial
Official title:
Validity of Strain Elastography for the Evaluation of Chronic Allograft Nephropathy
Verified date | December 2022 |
Source | Kasr El Aini Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic allograft nephropathy is one of dreaded complication of kidney transplant. It is one of the major determinants of long term graft survival. There are a number of factors that can contribute to chronic allograft nephropathy including chronic use of calcineurin inhibitors. Renal biopsy is the investigation of choice to detect chronic renal allograft nephropathy. renal biopsy has a number of complications . This includes infection and bleeding. The non invasive renal sono-elastography (strain and Shear Wave Imaging) technique has shown very good yield of detecting and scoring fibrosis. In this study our aim is to determine the sensitivity and specificity of ( strain sono-elastography) in the detection and classifying of chronic allograft nephropathy as compared to transcutaneous renal biops
Status | Completed |
Enrollment | 188 |
Est. completion date | October 24, 2022 |
Est. primary completion date | July 13, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years to 55 Years |
Eligibility | Inclusion Criteria: Renal transplant patients of more than 2 years duration, Chronic allograft nephropathy proved by renal biopsy done within 1 month from the date of the strain elastography, Body mass index less than 30 kg/m2, Skin allograft distance of less than 3.5 cm, Parenchyma thickness of more than 1 cm and no fluid accumulation around the allograft. Exclusion Criteria: Body mass index more than 30 kg/m2, Skin allograft distance more than 3.5 cm, Parenchymal thickness less than 1 cm, Presence of any fluid collection around the allograft, GFR less than 15 ml/min, Graft stones or backpressure and less than 14 years old or more than 55 years old. |
Country | Name | City | State |
---|---|---|---|
Egypt | Cairo university hospitals | Cairo |
Lead Sponsor | Collaborator |
---|---|
Kasr El Aini Hospital |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Grade of fibrosis | degree of fibrosis obtained by elastography | At the time of recruitment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01346397 -
Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
|
N/A | |
Recruiting |
NCT00999258 -
Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
|
Phase 4 | |
Completed |
NCT01265615 -
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
|
Phase 4 | |
Recruiting |
NCT00541814 -
Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
|
Phase 4 | |
Not yet recruiting |
NCT00659620 -
Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
|
Phase 1/Phase 2 | |
Completed |
NCT01056835 -
Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy
|
Phase 3 | |
Completed |
NCT00975000 -
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
|
Phase 3 | |
Terminated |
NCT00568477 -
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
|
Phase 2 | |
Completed |
NCT00007787 -
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
|
N/A | |
Completed |
NCT00005010 -
Prevention of Kidney Transplant Rejection
|
Phase 3 |